Metformin + Insulin Comparable to Insulin Alone in T2DM

More data needed to determine whether combined use of oral therapy and insulin adds benefit

FRIDAY, April 20 (HealthDay News) -- For patients with type 2 diabetes, treatment with metformin and insulin has no significant effect on all-cause or cardiovascular mortality, compared with insulin alone, although data are limited and suffer from bias, according to a meta-analysis published online April 19 in BMJ.

Bianca Hemmingsen, from the Copenhagen University Hospital in Denmark, and colleagues reviewed the literature to compare the benefits and harms of metformin and insulin versus insulin alone for type 2 diabetes. A total of 23 randomized clinical trials were eligible, involving 2,117 patients with diabetes; all of the trials had a high risk of bias.

The researchers found that, compared with insulin alone, metformin and insulin had no significant effect on all-cause mortality or cardiovascular mortality. Before reliable conclusions could be drawn regarding these outcomes, trial sequential analyses showed that more trials were needed. Severe hypoglycemia was significantly more frequent with metformin and insulin versus insulin alone in the fixed, but not random, effect model. Compared with insulin alone, metformin and insulin lead to a reduction in glycated hemoglobin, weight gain, and insulin dose in a random effects model. Based on trial sequential analyses, the evidence was sufficient for a 0.5 percent reduction in glycated hemoglobin, 1 kg lower weight, and insulin dose reduction of 5 U/day with metformin and insulin.

"There was no evidence or even a trend towards improved all-cause mortality or cardiovascular mortality with metformin and insulin, compared with insulin alone in type 2 diabetes," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events